SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021103
Filing Date
2024-05-23
Accepted
2024-05-23 09:27:30
Documents
13
Period of Report
2024-05-23
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40268
  Complete submission text file 0001493152-24-021103.txt   213343

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20240523.xsd EX-101.SCH 3018
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20240523_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20240523_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3699
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 24975401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)